Ukraine continues to demonstrate resilience and progress in clinical research, even in the face of challenging circumstances. Positioned at the heart of Eastern Europe, the country is steadily strengthening its role as an attractive hub for clinical trials.
• 249 active clinical trials as of July 2025
• 46 new studies approved by the Ministry of Health
• 3 Expanded Access Programs launched: Macitentan, Sasanlimab, Crizotinib
The Ukrainian government is actively working to simplify and streamline the processes for conducting clinical trials, helping to create a more efficient and research-friendly environment.
Ongoing collaboration with the European Commission and the Danish Medicines Agency, including Ukraine’s participation in strategic healthcare cooperation with Denmark, further underlines the country’s commitment to EU-aligned regulatory standards.
At PVR, with a dedicated presence in Ukraine, we are proud to support meaningful research that prioritizes science, patient access, and integrity.
Download the full report by the State Expert Center of the MoH of Ukraine HERE. 
.png)
.svg)
.svg)
.svg)
